Camber Capital Management

Latest statistics and disclosures from Camber Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are SPY, TEVA, GSK, MASI, GHDX. These five stock positions account for 40.21% of Camber Capital Management's total stock portfolio.
  • Added to shares of these 10 stocks: SPY (+$205.54M), LH (+$53.95M), MDCO (+$36.52M), BSX (+$33.12M), Pfenex (+$31.15M), KND (+$27.27M), GSK (+$23.51M), BRKR (+$19.62M), ALR (+$19.00M), Ptc Therapeutics I (+$18.99M).
  • Started 10 new stock positions in AFFX, LH, MDCO, ALR, BSX, Trevena, Eagle Pharmaceuticals, KND, SPY, Pfenex.
  • Reduced shares in these 10 stocks: (-$44.92M), VOLC (-$44.70M), MYL (-$36.64M), (-$32.44M), DGX (-$20.28M), (-$17.82M), BRLI (-$17.10M), NVAX (-$16.31M), (-$14.19M), Otonomy (-$13.75M).
  • Sold out of its positions in ACHN, GERN, ICUI, Otonomy, VRTX, WCG.
  • As of Dec. 31, 2014, Camber Capital Management has $1.48B in assets under management (AUM). Assets under management grew from a total value of $1.06B to $1.48B.
  • Independent of market fluctuations, Camber Capital Management was a net buyer by $284.75M worth of stocks in the most recent quarter.

Camber Capital Management portfolio companies for December 2014 quarter

Ticker Name Portfolio Weight Change Share Count Price Last Trade
SPY SPDR S&P; 500 ETF 13.86 NEW 1000000 205.54 209.74
TEVA Teva Pharmaceutical Industries 8.73 2250000 57.51 56.44
GSK GlaxoSmithKline 7.93 +25.00% 2750000 42.74 47.21
MASI Masimo Corporation 5.06 +5.00% 2850000 26.34 30.86
GHDX Genomic Health 4.64 +7.00% 2150000 31.97 31.90
CNMD CONMED Corporation 4.20 1385000 44.96 51.42
Express Scripts Holding 4.00 700000 84.67 0.00
LH Laboratory Corp. of America Holdings 3.64 NEW 500000 107.90 122.28
ARIA Ariad Pharmaceuticals 3.47 +25.00% 7500000 6.87 8.25
VOLC Volcano Corporation 3.07 -49.00% 2550000 17.88 17.99
AMAG AMAG Pharmaceuticals 2.87 +33.00% 1000000 42.62 51.39
KERX Keryx Biopharmaceuticals 2.86 -14.00% 3000000 14.15 12.88
Universal American 2.86 +9.00% 4568898 9.28 0.00
MYL Mylan 2.85 -46.00% 750000 56.37 56.43
BRKR Bruker Corporation 2.65 +100.00% 2000000 19.62 19.14
Orthofix International Nv Com Stk 2.53 +3.00% 1250000 30.06 0.00
MDCO Medicines Company 2.46 NEW 1320000 27.67 29.56
BSX Boston Scientific Corporation 2.23 NEW 2500000 13.25 16.97
SQNM Sequenom 2.18 +9.00% 8750000 3.70 3.67
Pfenex 2.10 NEW 1000000 31.15 0.00
WTW Weight Watchers International 1.92 +14.00% 1146741 24.84 9.73
KND Kindred Healthcare 1.84 NEW 1500000 18.18 21.95
Ptc Therapeutics I 1.83 +231.00% 525000 51.77 0.00
GNMK GenMark Diagnostics 1.60 +92.00% 1748100 13.61 12.72
ALR Alere 1.28 NEW 500000 38.00 46.27
CCRN Cross Country Healthcare 1.20 +42.00% 1422565 12.48 10.96
Trevena 1.16 NEW 2870000 5.98 0.00
DGX Quest Diagnostics Incorporated 0.89 -60.00% 197622 67.06 72.31
NVAX Novavax 0.80 -57.00% 2000000 5.93 8.88
AMRN Amarin Corporation 0.79 12000000 0.98 1.67
AFFX Affymetrix 0.67 NEW 1000000 9.87 12.19
ANGO AngioDynamics 0.47 364630 19.01 18.53
CRDC Cardica 0.40 8374846 0.70 0.55
TRGT Targacept 0.28 1560000 2.63 2.60
PLX Protalix BioTherapeutics 0.25 2000000 1.84 1.88
Eagle Pharmaceuticals 0.21 NEW 200400 15.50 0.00
Inovio Pharmaceuticals 0.15 250000 9.18 0.00
BLTI Biolase Technology 0.04 +172.00% 7388867 0.08 0.00
BRLI Bio-Reference Laboratories 0.02 -97.00% 11485 32.13 33.71

Past 13F-HR SEC Filings for Camber Capital Management